The Role of Proton Pump Inhibitors in the Treatment of Barrett’s Esophagus
Barrett’s esophagus (BE), as a more frequent complication of gastroesophageal reflux disease, is a metaplastic condition in which the normal squamous epithelium of the esophagus is replaced by specialized intestinal metaplastic epithelium, and that, in about 10% of patients with gastroesophageal ref...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/87005 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Role of Proton Pump Inhibitors in the Treatment of Barrett’s Esophagus
- Diagnosis and Management of Barrett’s Esophagus with and Without Dysplasia
- Esophageal cancer and Barrett's esophagus /
- Gastroesophageal Reflux Disease: Molecular Predictors in Neoplastic Progression of Barrett's Esophagus
- Long-term impact of proton pump inhibitors in patients with prolonged treatment in Latin America
- Vonoprazan Versus Conventional Proton Pump Inhibitor in the Therapeutic Armamentarium of Peptic Ulcer Disease and Gastroesophageal Reflux Disease
- Large Language Models for Granularized Barrett's Esophagus Diagnosis Classification